Metastatic Cancers: Clinical Trials

2 trials for Metastatic Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Metastatic Cancers: new trials by email Literature Review of Metastatic Cancers trials Research Report on Metastatic Cancers

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
REC-1245 - Unresectable, Locally Advanced
Phase 1 / Phase 2RecruitingRecursion Pharmaceuticals Inc.1702024-11-212026-08-20
RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Pembrolizumab, Radiotherapy - Metastatic Cancers
Phase 1CompletedAbramson Cancer Center at Penn Medicine592015-01-082021-05-12

Narrower conditions

Neoplasms (2)  ·  Lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Radiotherapy (1)  ·  pembrolizumab (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Recursion Pharmaceuticals Inc. (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Amit Maity, MD, PhD (1)

Results publications

PMID 30318516